8.90 +0.14 (1.66%)
After hours: 7:56PM EDT
|Bid||8.74 x 2200|
|Ask||8.82 x 4000|
|Day's range||8.71 - 8.94|
|52-week range||6.42 - 22.99|
|Beta (5Y monthly)||0.92|
|PE ratio (TTM)||N/A|
|Earnings date||29 Jul 2020 - 03 Aug 2020|
|Forward dividend & yield||2.00 (22.88%)|
|Ex-dividend date||30 Mar 2020|
|1y target est||10.50|
The Board of Directors of Chimera announced the declaration of its second quarter cash dividend of $0.50 per share of 8% Series A Cumulative Redeemable Preferred Stock. The dividend is payable June 30, 2020 to preferred shareholders of record on June 10, 2020. The ex-dividend date is June 9, 2020.
The last couple of months have been a crucible for mortgage real estate investment trusts (mREITs). The COVID-19 crisis has caused extreme volatility in the bond markets, and mortgage-backed securities generally abhor volatility. Every mREIT has a different investment strategy, and pretty much every one has reacted in its own way.
During this call, we will be making forward-looking statements, which are predictions, projections or other statements about future events. Actual events and results may differ materially from these forward-looking statements.
Chimera Investment Corporation (NYSE:CIM) today announced its financial results for the first quarter ended March 31, 2020. The Company’s GAAP net loss for the first quarter was $(389) million, or $(2.08) per common share. Core earnings(1) for the first quarter was $106 million, or $0.57 per common share.
Chimera Investment Corporation (NYSE: CIM) (the "Company") announced today that it plans to release its financial results for the first quarter ended March 31, 2020 on Wednesday, May 6, 2020 prior to 7:00 a.m. EDT. The Company will conduct a conference call and audio webcast to discuss the results on Wednesday, May 6, 2020 at 9:00 a.m. EDT.
Chimera Investment Corporation (NYSE: CIM) (the "Company") today announced the pricing of an underwritten public offering of $325 million aggregate principal amount of its 7.00% convertible senior notes due 2023 (the "Notes") at an issue price of 100%, plus accrued interest, if any, from April 13, 2020. The offering is expected to close on April 13, 2020 and is subject to customary closing conditions. The Company has granted the underwriter an option to purchase up to an additional $48.75 million aggregate principal amount of the Notes to cover over-allotments.
Chimera Investment Corporation (NYSE: CIM) (the "Company") today announced that it has commenced an underwritten public offering of $250.0 million aggregate principal amount of convertible senior notes due 2023 (the "Notes"), subject to market and other conditions. The Company expects to grant the underwriter a 13-day option to purchase up to an additional $37.5 million aggregate principal amount of the Notes to cover over-allotments. The Notes will be senior unsecured obligations of the Company.
Chimera Investment Corporation ("Chimera" or the "Company") announced that at close of business on March 27, 2020 Chimera estimates that its GAAP book value per share is between $12.25 and $12.75.
In light of recent market events, Chimera Investment Corporation ("Chimera" or the "Company") announced a $150 million common stock buyback on March 13th and through March 17th Chimera has repurchased $22 million of its common stock. In addition, Officers and Directors have purchased shares.
Chimera Investment Corporation (NYSE:CIM) today announced its Board of Directors has authorized the repurchase of up to $150 million of its outstanding common shares. The share repurchase program is expected to be funded through the Company’s existing capital. The repurchase program announced today replaces the Company’s previously disclosed share repurchase program (of which, as of the date hereof, approximately $85 million was available).
Chimera (CIM) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Chimera (CIM) delivered earnings and revenue surprises of -1.96% and -0.64%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?